DUBLIN--(BUSINESS WIRE)--The "2019 Tumor Marker Testing Market Competitive Landscape: Strategic Assessments of Leading Suppliers" report has been added to ResearchAndMarkets.com's offering.
This new 80-page report provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.
The assessments include:
- Sales
- Product portfolios
- Distribution tactics
- Technological know-how
- New products in R&D
- Collaborative arrangements
- Business strategies.
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako
For more information about this report visit https://www.researchandmarkets.com/r/yu9cus
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
